TORNTPHARM.BO

TORRENT PHARMACEUTICALS LTD. · Healthcare · Drug Manufacturers - Specialty & Generic

Earnings call summary →

—

Loading quote…

Highlights

Market Cap

$15.57B

PE Ratio

65.78

EV to Ebitda

—

Earnings Yield

2.00%

Revenue (TTM)

$1.28B

Net Income (TTM)

$236.8M

Revenue (Annual YoY Growth)

—

Revenue (Quarterly YoY Growth)

14.00%

Profit Margin

17.00%

Return on Equity

—

Debt to Equity Ratio

0.31

Dividend Yield

—

All fundamentals

Core6 fields›

Market Cap$15.57B

Revenue TTM$1.28B

Shares Outstanding338.4M

Float96942493

Insider Ownership71.00%

Institutional Ownership15.00%

Growth Estimates5 fields›

Revenue Growth (Quarterly YoY)14.00%

Rev Growth Est 1Y Forward0.13

EPS Growth (Quarterly YoY)30.00%

EPS Growth Est Quarterly18.66

LT EPS Growth Estimates24.00%

Operations16 fields›

Revenue TTM$1.28B

Gross Margin TTM76.00%

Gross Margin (Quarterly)75.00%

Operating Margin TTM27.00%

Operating Margin (Quarterly)27.00%

Operating Expenses TTM$21.3M

Profit Margin TTM17.00%

Profit Margin (Quarterly)20.00%

Net Income TTM$236.8M

EPS TTM63.25

EPS (Quarterly)18.76

EBITDA Margin TTM32.00%

EBITDA TTM$411.4M

Capex % of Revenue TTM0.00%

Capital Expenditures$0.00M

FCF % of Revenue (Quarterly)16.00%

Efficiency1 fields›

ROA13.00%

Valuation8 fields›

P/E (TTM)65.78

P/E Forward58.48

PEG0.34

EV/Revenues (TTM)11.92

Price To Book17.69

Price to Tangible Book36.76

Earnings Yield2.00%

Payout Ratio67.00%

Liquidity8 fields›

Current Ratio1.19

Goodwill & Intangibles$43830.00T

Total Assets$1.62B

Total Liabilities$3.15B

Shareholders Equity$880.5M

Debt to Equity0.31

Interest Expense$21.3M

Goodwill % of Assets28250081.00%

Yields3 fields›

Payout Ratio67.00%

Earnings Yield2.00%

Buyback Yield0.00%